NIH-funded research R01 grant

Understanding how certain genes help the immune system fight viral infections

Official title: Retroviral infection and new modulators of the MHCII pathway

Funded at University of Chicago · NIH-11113876 · Data updated 2026-11-12

This study is looking at how certain genes help our immune system make antibodies that fight off long-lasting viral infections, like hepatitis B and C, and it aims to find ways to improve treatments for people dealing with these viruses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startJune 12, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$793,725
NIH project number5R01AI175279-02
Project IDNIH-11113876 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with chronic viral infections such as hepatitis B or C, particularly those who exhibit varying immune responses.

Less likely to help

Patients with acute viral infections or those without a history of viral infections may not receive direct benefits from this research.

What this research studies

This research investigates how specific genes influence the immune system's ability to produce neutralizing antibodies against persistent viral infections. By studying both mice and humans, the researchers aim to uncover the mechanisms that enable some individuals to effectively control viruses like hepatitis B and C. The study employs advanced genetic analysis and bioinformatics to identify variations in genes that may affect immune responses. Patients may benefit from insights that could lead to improved treatments for viral infections.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing the immune response against viral infections in patients.

How similar studies have gone: Previous research has shown success in understanding immune responses to viral infections, making this approach promising yet still exploring novel genetic factors.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Golovkina, Tatyana V — University of Chicago
  • Study coordinator: Golovkina, Tatyana V

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.